Business Description
Biomea Fusion Inc
NAICS : 325412
SIC : 2834
ISIN : US09077A1060
Description
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 9.19 | |||||
| Equity-to-Asset | 0.69 | |||||
| Debt-to-Equity | 0.13 | |||||
| Debt-to-EBITDA | -0.06 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -94.4 | |||||
| 3-Year EPS without NRI Growth Rate | -90.6 | |||||
| 3-Year FCF Growth Rate | -90.9 | |||||
| 3-Year Book Growth Rate | 191.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 4.95 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 23.1 | |||||
| 9-Day RSI | 23.64 | |||||
| 14-Day RSI | 25.34 | |||||
| 6-1 Month Momentum % | 16.04 | |||||
| 12-1 Month Momentum % | -55 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.39 | |||||
| Quick Ratio | 3.39 | |||||
| Cash Ratio | 3.19 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.6 | |||||
| Shareholder Yield % | -0.15 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -105.26 | |||||
| ROA % | -85.71 | |||||
| ROIC % | -572.48 | |||||
| ROC (Joel Greenblatt) % | -1045.42 | |||||
| ROCE % | -104.65 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.92 | |||||
| Price-to-Tangible-Book | 1.92 | |||||
| EV-to-EBIT | -0.5 | |||||
| EV-to-Forward-EBIT | -0.43 | |||||
| EV-to-EBITDA | -0.5 | |||||
| EV-to-Forward-EBITDA | -0.43 | |||||
| EV-to-Forward-Revenue | 9.02 | |||||
| EV-to-FCF | -0.6 | |||||
| Price-to-Net-Current-Asset-Value | 2.46 | |||||
| Price-to-Net-Cash | 2.71 | |||||
| Earnings Yield (Greenblatt) % | -200 | |||||
| FCF Yield % | -77.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BMEA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biomea Fusion Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -4.01 | ||
| Beta | -0.56 | ||
| Volatility % | 95.91 | ||
| 14-Day RSI | 25.34 | ||
| 14-Day ATR ($) | 0.548406 | ||
| 20-Day SMA ($) | 5.70625 | ||
| 12-1 Month Momentum % | -55 | ||
| 52-Week Range ($) | 3.61 - 20.21 | ||
| Shares Outstanding (Mil) | 36.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biomea Fusion Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biomea Fusion Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biomea Fusion Inc Frequently Asked Questions
What is Biomea Fusion Inc(BMEA)'s stock price today?
The current price of BMEA is $4.01. The 52 week high of BMEA is $20.21 and 52 week low is $3.61.
When is next earnings date of Biomea Fusion Inc(BMEA)?
The next earnings date of Biomea Fusion Inc(BMEA) is 2025-03-28 Est..
Does Biomea Fusion Inc(BMEA) pay dividends? If so, how much?
Biomea Fusion Inc(BMEA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers